Cairo Pharmaceuticals is one of Egypt's oldest drugmakers, a state-backed producer whose profits have nearly doubled in a single year. The jump reflects both higher sales and a company finally earning a return worthy of its long history. Full nameCairo Pharmaceuticals and Chemical Industries Tickers / exchangeCPCI / Egyptian Exchange (EGX) HeadquartersCairo, Egypt SectorPharmaceuticals EmployeesNot published in available sources Market valueNot published in available sources Yearly salesEGP 2,079,340,000 (US$39.8 million) — FY ended 30 June 2025 Net profitEGP 443,721,265 (US$8.5 million) — FY ended 30 June 2025 Net margin21.3% (our …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →